HEPATIC CANCER STAGE III

This adverse event was reported 446 times

HEPATIC CANCER STAGE III is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ETHIODIZED OIL 1 0.0008
1 RANITIDINE HYDROCHLORIDE 16 0.0003
2 ABROCITINIB 1 0.0003
3 RANITIDINE 27 0.0001
4 REGORAFENIB 1 0.0001
5 SORAFENIB 1 0.0000
6 RIFAXIMIN 1 0.0000
7 GLIMEPIRIDE 1 0.0000
8 PANCRELIPASE 1 0.0000
9 DULOXETINE HYDROCHLORIDE 1 0.0000
See all drugs enriched for association with HEPATIC CANCER STAGE III